Back to CVE records
Medium 5.3Published Sep 30, 2026

CVE-2026-102845gedelumbung HospitalManagement HTTP Response index.php error_reporting information disclosure

Updated under an hour ago ()

Does this affect you?

It affects gedelumbung HospitalManagement. Add what you run to find out whether that includes you.

No exploitation reported and no EPSS estimate yet.

A security vulnerability has been detected in gedelumbung HospitalManagement up to c2d45543789a3887067d3915f69d44cfc2cf76a8. This issue affects the function error_reporting of the file index.php of the component HTTP Response. The manipulation leads to information disclosure. The attack may be initiated remotely. The exploit has been disclosed publicly and may be used. This product uses a rolling release model to deliver continuous updates. As a result, specific version information for affected or updated releases is not available. The project was informed of the problem early through an issue report but has not responded yet.

CVSS
5.3 MEDIUM (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N/E:P/RL:X/RC:C
Weakness (CWE)
CWE-200, CWE-284
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
Not loaded for this CVE
Assigned by
VulDB
NVD analysis
Deferred
Record last updated
Sep 30, 2026
First seen by InfoSec Signals
Oct 9, 2026

Affected products

Affected products
gedelumbung HospitalManagement
gedelumbung:hospitalmanagement
c2d45543789a3887067d3915f69d44cfc2cf76a8
CNA record

References

  • vdb-entry, technical-description
  • signature, permissions-required
  • third-party-advisory
  • third-party-advisory
  • exploit, issue-tracking
  • product

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.